Redmile Group, LLC Gossamer Bio, Inc. Transaction History

Redmile Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$9.52 - $15.98 $2.47 Million - $4.15 Million	-259,700 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$8.0 - $15.48 $4,800 - $9,288	-600 Reduced 0.23%	259,700 $2.64 Million
Q4 2019 Feb 14, 2020	SELL	$14.82 - $26.79 $2,964 - $5,358	-200 Reduced 0.08%	260,300 $4.07 Million
Q3 2019 Nov 14, 2019	BUY	$16.02 - $22.47 $190,638 - $267,393	11,900 Added 4.79%	260,500 $4.37 Million
Q2 2019 Aug 14, 2019	SELL	$16.12 - $22.89 $22,568 - $32,046	-1,400 Reduced 0.56%	248,600 $5.51 Million
Q1 2019 May 15, 2019	BUY	$17.58 - $23.97 $4.4 Million - $5.99 Million	250,000 New	250,000 $5.42 Million

108

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $80.8M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Redmile Group, LLC with notifications on news.